You are currently viewing a new version of our website. To view the old version click .

Marine Transcriptomic

Special Issue Information

Dear Colleagues,

Advances in bioinformatics and the increasing availability of sequenced genomes and transcriptomes provide more opportunities than ever in the discovery of novel bioactive compounds and biocatalysts from marine organisms.

In silico analysis of genomic or transcriptomic data is easier and more efficient today thanks to the development of new bioinformatics tools allowing access to multiple pieces of information and functionalities.

RNA-Sequencing allows detecting both known and novel features, to access differential expressions, gene networks, functions likely to reveal new molecules of interest.

For example, many microorganisms have the potential to produce a far greater number of natural products than have been isolated to date, since most biosynthetic gene clusters are either silent or expressed at very low levels when they are cultured under standard laboratory conditions.

On the other hand, in silico analysis of transcriptomes from other marine organisms such as venomous animals or organisms from extreme environments provides a considerable opportunity to identify new molecules with global health potential.

The identification of biosynthetic gene and gene clusters through a bioinformatics approach and their synthesis by eventual heterologous expression, will give a great impulse for natural products identification and drug discovery from marine organisms.

Dr. Céline Zatylny-Gaudin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • marine organisms
  • bioinformatics
  • biosynthetic gene
  • transcriptomes
  • gene clusters
  • heterologous expression
  • drug discovery
  • in silico analysis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Mar. Drugs - ISSN 1660-3397